NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma
Serine–threonine protein kinase B-RAF <b>(</b><i>BRAF)</i>-mutated metastatic melanoma (MM) is a highly aggressive type of skin cancer. Treatment of MM patients using BRAF/MEK inhibitors (BRAFi/MEKi) eventually leads to drug resistance, limiting any clinical benefit...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Multidisciplinary Digital Publishing Institute
2021
|
Online Access: | https://hdl.handle.net/1721.1/131328 |